Bortezomib Reverses a Post-Translational Mechanism of Tumorigenesis Forpatched1haploinsufficiency in Medulloblastoma
Pediatric Blood and Cancer - United States
doi 10.1002/pbc.21968
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2009
Authors
Publisher
Wiley